New drug NSHO-101 enters first human safety tests
NCT ID NCT07403552
First seen Feb 19, 2026 · Last updated May 17, 2026 · Updated 9 times
Summary
This early-stage study is testing a new drug, NSHO-101, in 24 healthy adults. The main goal is to see how the body handles the drug and whether it is safe. Participants must be in good health and willing to follow study rules. This research does not aim to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cenexel Anaheim CA
RECRUITINGAnaheim, California, 92801, United States
Conditions
Explore the condition pages connected to this study.